78 件 ・ 関連度順
概要と使いどころ
Use when building native Android with Jetpack Compose - stateless composables, state hoisting, ViewModel-owned state, edge-to-edge, predictive back, adaptive layout, atomic components, and Material theming over hardcoded values
日本語の概要は準備中です。原文の説明を表示しています。
予測モデリング（教師あり機械学習 / 予測モデル / 精度評価 / 交差検証 / リーク、決定木 / ランダムフォレスト / GBDT / LightGBM / XGBoost / CatBoost、モデル解釈 / 特徴量重要度 / SHAP / PDP / ICE、時系列 / 季節性 / ARIMA / SARIMA / Prophet / VAR / 変化点 / 時系列予測）を実行したら必ずセットで出す図と値のルーター。train_test_split, cross_val_score, GridSearchCV, Pipeline, TimeSeriesSplit, DecisionTree, RandomForest, lgb., xgb., CatBoost, dtreeviz, shap., permutation_importance, PartialDependenceDisplay, statsmodels.tsa, SARIMAX, STL, adfuller, plot_acf, Prophet, ruptures がコードに現れたとき、または ユーザーが「予測モデルを作って」「精度を出して」「どの変数が効いているか」「来月を予測して」「季節性を見て」と 言ったときに使う。診断・リーク・ベースライン・残差に言及がなくても適用する。SKILL.md のルーティング表で手法を特定し、 対応する references/<手法>.md を読んでから実行する。回帰係数の推論・検定は statistical-inference-diagnostics、 効果推定は causal-inference-diagnostics を使う。
Act as an end-to-end data scientist: turn business questions into defensible analysis, validated models, and decision-ready reports. Use whenever the user asks to analyze, explore, or profile a dataset or CSV/Parquet/Excel file; asks what drives a metric or why a number changed ("why did churn go up?"); wants to test whether a difference is real (A/B tests, experiments, "is this significant?", "how many samples do I need?"); wants a predictive model (churn, forecast, scoring, segmentation, classification, regression); asks to review an existing analysis, notebook, or model for flaws; or needs results written up for decision-makers. Triggers in any language ("phân tích dữ liệu", "xây model dự đoán", "kiểm định A/B"), even when they never say "data science" or "statistics".
日本語の概要は準備中です。原文の説明を表示しています。
Supervised and unsupervised learning, bias-variance tradeoff, cross-validation, decision trees, ensemble methods, neural network fundamentals, and the practitioner's workflow from problem framing through deployment. Covers classification, regression, clustering, dimensionality reduction, regularization, hyperparameter tuning, and evaluation metrics. Use when building predictive models, selecting algorithms, or understanding the machine learning pipeline.
日本語の概要は準備中です。原文の説明を表示しています。
Bridge active inference theory with robot control using K-Scale's JAX/MuJoCo stack. Use when connecting predictive coding to locomotion policies, mapping KL divergence minimization to RL training, applying mean field approximation to robotics state estimation, or implementing sim2real as inference about future observations.
日本語の概要は準備中です。原文の説明を表示しています。
Generate and optimise novel small molecules with REINVENT 4 — de novo sampling from a chemical language model, scaffold decoration with LibInvent, fragment linking with LinkInvent, and similarity-constrained analogue generation with Mol2Mol. Use this skill to set up reinforcement-learning or curriculum runs, compose a multi-parameter scoring function from docking scores, predictive models, and physicochemical desirability, and read the resulting sampled sets. Also trigger on REINVENT, LibInvent, LinkInvent, Mol2Mol, scaffold hopping, R-group replacement, linker design, chemical language model, or reinforcement-learning molecule optimisation.
日本語の概要は準備中です。原文の説明を表示しています。
Analyze mining equipment maintenance systems including heavy fleet condition monitoring (oil analysis, vibration per ISO 17359/10816, thermal imaging), predictive analytics with Weibull reliability modeling and remaining useful life estimation.
日本語の概要は準備中です。原文の説明を表示しています。
Analyze preventive and predictive maintenance scheduling systems including CMMS/EAM work order optimization, asset condition scoring with Facility Condition Index, PM compliance tracking, maintenance backlog reduction, reliability-centered maintenance strategy.
日本語の概要は準備中です。原文の説明を表示しています。
Use when learning, designing, or explaining Salesforce Reports and Dashboards from first principles — report types, custom report types, groupings, bucket fields, summary formulas, charts, dashboard components, dynamic dashboards, report subscriptions, and folder permissions. Triggers: 'how do I build a report', 'what report type should I use', 'set up a dashboard', 'joined report limits', 'bucket field vs formula', 'dynamic dashboard running user'. NOT for CRM Analytics (use crm-analytics-* skills). NOT for Einstein Discovery predictive analytics. NOT for troubleshooting missing report data caused by sharing model issues (use admin/reports-and-dashboards for that).
日本語の概要は準備中です。原文の説明を表示しています。
Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.
日本語の概要は準備中です。原文の説明を表示しています。
Mint a new YYYY-MM-DD-exact-coding-baseline snapshot under research/workflow-dev/export/. Detects the current best correctness- oriented workflow from research/workflow-dev/workflow-construction.md (or takes an explicit source-workflow argument) and transforms it from a lab workflow into a consumer-ready one on three axes: strips lab-only measurement content, re-enables human-in-the-loop checkpoints, and converts auto-loading config into an explicitly-invoked skill. Supports both promoted EXACT Coding lines: Opus/Hybrid and SOL/Predictive TDD. Exports Claude Code, pi, OpenCode, cursor-agent and, for SOL, Copilot. Trigger when the user says "exact-coding baseline export", "neue exact-coding baseline", "exact-coding-baseline-export", or asks to refresh the baseline snapshot.
日本語の概要は準備中です。原文の説明を表示しています。
Comprehensive data science workflow skill for analyzing tabular and time series data. Use when conducting exploratory data analysis, building predictive models, performing feature engineering, or generating data-driven insights. Supports end-to-end analysis from data understanding through model deployment, following industry best practices for regression, classification, time series forecasting, and statistical analysis.
日本語の概要は準備中です。原文の説明を表示しています。
Knowledge base from the SD-22 DMSMS Guidebook (DSPO, FY24 working draft). Use for managing Diminished Manufacturing Sources and Material Shortages (DMSMS) and obsolescence across a long-lived system's life cycle: the five-step process (Prepare, Identify, Assess, Analyze, Implement) plus the Strategize overlay; standing up a DMSMS Management Team (DMT) and Management Plan (DMP); risk-based monitoring and surveillance (the risk cube, predictive tools, vendor surveys, GIDEP/DLA PDNs, critical-materials analysis); health assessments and resolution timing; costing and selecting resolutions (life-of-need buys, substitutes, redesign, technology refreshment) by AoA/BCA; and budgeting/executing resolutions through modification funding and the ECP process. Defense-sustainment / DoD-acquisition framing throughout. Does NOT teach general systems engineering, parts-management standards, or contracting law in depth, and does not reproduce DoD policy text or the source's tables and figures.
日本語の概要は準備中です。原文の説明を表示しています。
Builds native Android apps with the Android team's guides — Jetpack Compose UI, adaptive layouts, edge-to-edge, Compose styles, migrating XML views to Compose, Navigation 3 and predictive back; Android Gradle Plugin 9 upgrades, R8 keep rule analysis, profiling with Android Studio and Perfetto, and the Android CLI; Google Play policy compliance, Play Billing upgrades and the Engage SDK; Credential Manager restore and verified email; CameraX and Media3 Cast; App Functions and the ML Kit GenAI Prompt API; Wear OS, Android TV and display glasses. Use when writing, upgrading or auditing native Android (Kotlin) code for any of these topics, even if the user does not name the library.
日本語の概要は準備中です。原文の説明を表示しています。
Master modern business analysis with AI-powered analytics, real-time dashboards, and data-driven insights. Build comprehensive KPI frameworks, predictive models, and strategic recommendations.
日本語の概要は準備中です。原文の説明を表示しています。
Use for health trend, anomaly, disk forecast
日本語の概要は準備中です。原文の説明を表示しています。
Expert data scientist for advanced analytics, machine learning, and statistical modeling. Handles complex data analysis, predictive modeling, and business intelligence.
日本語の概要は準備中です。原文の説明を表示しています。
Master modern business analysis with AI-powered analytics, real-time dashboards, and data-driven insights. Build comprehensive KPI frameworks, predictive models, and strategic recommendations.
日本語の概要は準備中です。原文の説明を表示しています。
Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.
日本語の概要は準備中です。原文の説明を表示しています。
Builds and validates predictive time-to-event models on clinical and omics data with penalized Cox, random survival forests, gradient-boosted and deep survival models, and prediction-grade evaluation (Uno's C, time-dependent AUC, integrated Brier, calibration, competing risks). Use when building an individualized risk predictor or prognostic omics signature, choosing a survival model, or evaluating one beyond the C-index. For Kaplan-Meier, log-rank, and classical Cox hazard-ratio inference in a trial see clinical-biostatistics/survival-analysis.
日本語の概要は準備中です。原文の説明を表示しています。
Validates predictive models on omics and biomedical data with nested cross-validation, group/batch/temporal-aware splits, the full data-leakage taxonomy, probability calibration, decision-curve net benefit, optimism correction, sample-size planning, and TRIPOD+AI reporting. Use when estimating model performance honestly, choosing a CV scheme, detecting leakage, or judging whether reported discrimination means the model is actually useful. For feature selection itself see machine-learning/biomarker-discovery; for confirmatory-trial inference see clinical-biostatistics/trial-reporting.
日本語の概要は準備中です。原文の説明を表示しています。
Builds QSAR / QSPR models using chemprop D-MPNN, MolFormer, Uni-Mol, ChemBERTa, random forest baselines, and Gaussian processes with explicit handling of OECD 5 principles, applicability domain (kNN, leverage, conformal prediction, Mahalanobis), scaffold-balanced splits, ensemble uncertainty, calibration (Platt, isotonic), feature importance (SHAP, atomic attribution), and prospective validation. Use when building target-specific predictive models from in-house bioassay data, ADMET endpoints, or selectivity profiles.
日本語の概要は準備中です。原文の説明を表示しています。
Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.
日本語の概要は準備中です。原文の説明を表示しています。
Builds QSAR / QSPR models using chemprop D-MPNN, MolFormer, Uni-Mol, ChemBERTa, random forest baselines, and Gaussian processes with explicit handling of OECD 5 principles, applicability domain (kNN, leverage, conformal prediction, Mahalanobis), scaffold-balanced splits, ensemble uncertainty, calibration (Platt, isotonic), feature importance (SHAP, atomic attribution), and prospective validation. Use when building target-specific predictive models from in-house bioassay data, ADMET endpoints, or selectivity profiles.
日本語の概要は準備中です。原文の説明を表示しています。